START-UP’s monthly update on technology transfer deals—licensing agreements between companies and universities or other research institutions—in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.

Brief summaries of recent medtech market and industry developments. This month we cover positive developments in the aortic endograft market, new device regulatory approvals and financings, and growth in the market for endoscopic ENT procedures.

Affordability drives medical devices purchases and use. Even the most remarkable devices can see a tremendous downturn in usage is reimbursement is lowered. That's why an an annoucement that CMS is considering changes to coverage of certain medical procedures is making device company CEOs more than a little nervous.

Diabetogen Biosciences' therapies target the autoimmune component of Type I diabetes and may help prevent onset of the disease.